Although the RFS between the two treatment groups has not been statistically significant, we have seen a clear trend.
← all excerpts
Efficacy Analysis of Adjuvant Chemotherapy with Gemcitabine Plus Platinum or S-1 in Biliary Tract Carcinoma: A Multi-Center Retrospective Study.
1
—
—